Regulatory Affairs: A key capability for Sweden's Life Science competitiveness

05 oktober 2026
iStock-2150404554 (1)

As discussions continue around Sweden's ability to remain a competitive Life Science nation and ensure patient access to innovative medicines, one question becomes increasingly relevant:

Do we have the regulatory capabilities needed to support future growth?

Regulatory Affairs has evolved far beyond managing submissions and compliance. Today's regulatory professionals are expected to navigate increasingly complex regulatory environments, support development programs, contribute to strategic decision-making and collaborate across multiple functions.

At PharmaRelations, we see strong demand for Regulatory Affairs expertise across pharmaceuticals, medical devices and combination products. We help Life Science companies access experienced Regulatory Affairs professionals who can support everything from regulatory strategy and submissions to lifecycle management and market access activities.

Companies are increasingly looking for individuals who combine deep regulatory knowledge with business understanding, stakeholder management and the ability to navigate complexity across the product lifecycle.

The discussion around Sweden's future as a Life Science nation often focuses on innovation, investment and research. Equally important is ensuring access to the expertise required to translate innovation into products that can reach patients.

Regulatory Affairs professionals play a critical role in this process. By helping companies navigate regulatory requirements, align development strategies with regulatory expectations and support successful approvals, they contribute to bringing innovative therapies to patients faster and more effectively.

As regulatory complexity continues to increase, access to the right Regulatory Affairs competence will remain a critical factor for patient access, innovation and long-term competitiveness.

Strengthening Regulatory Affairs capabilities is therefore not only about managing compliance. It is about enabling innovation and helping ensure that more new therapies reach Swedish patients.

Innovation depends on the right expertise. Contact Shiva Hobbi Nowzari to discuss how Regulatory Affairs competence can help accelerate patient access and business growth.

Contact
Shiva Hobbi Nowzari, Consultant Manager
+46 70 165 22 64 | shiva.nowzari@pharmarelations.se

Cookies

This website use cookiesfor statistic and user experience.

Pharmarelations uses cookies to improve your user experience, to give basis for improvement and further development of the website and to be able to direct more relevant offers to you. Please read our personal data policy. If you agree to our use, select Allow All. If you want to change your choice afterwards, you will find that option at the bottom of the page.